Cited 0 times in 
Cited 0 times in 
An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive recurrent cervical cancer
https://orcid.org/0000-0001-7948-1350Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.